1613 related articles for article (PubMed ID: 26133902)
21. Randomised clinical trial: the safety and efficacy of AST-120 in non-constipating irritable bowel syndrome - a double-blind, placebo-controlled study.
Tack JF; Miner PB; Fischer L; Harris MS
Aliment Pharmacol Ther; 2011 Oct; 34(8):868-77. PubMed ID: 21883322
[TBL] [Abstract][Full Text] [Related]
22. Effect of ramosetron on stool consistency in male patients with irritable bowel syndrome with diarrhea.
Fukudo S; Ida M; Akiho H; Nakashima Y; Matsueda K
Clin Gastroenterol Hepatol; 2014 Jun; 12(6):953-9.e4. PubMed ID: 24315882
[TBL] [Abstract][Full Text] [Related]
23. Efficacy, safety, and tolerability of plecanatide in patients with irritable bowel syndrome with constipation: results of two phase 3 randomized clinical trials.
Brenner DM; Fogel R; Dorn SD; Krause R; Eng P; Kirshoff R; Nguyen A; Crozier RA; Magnus L; Griffin PH
Am J Gastroenterol; 2018 May; 113(5):735-745. PubMed ID: 29545635
[TBL] [Abstract][Full Text] [Related]
24. Randomised clinical trial: Tong-Xie-Yao-Fang granules versus placebo for patients with diarrhoea-predominant irritable bowel syndrome.
Chen M; Tang TC; Wang Y; Shui J; Xiao XH; Lan X; Yu P; Zhang C; Wang SH; Yao J; Zheng H; Huang DQ
Aliment Pharmacol Ther; 2018 Jul; 48(2):160-168. PubMed ID: 29856472
[TBL] [Abstract][Full Text] [Related]
25. Rifaximin therapy for patients with irritable bowel syndrome without constipation.
Pimentel M; Lembo A; Chey WD; Zakko S; Ringel Y; Yu J; Mareya SM; Shaw AL; Bortey E; Forbes WP;
N Engl J Med; 2011 Jan; 364(1):22-32. PubMed ID: 21208106
[TBL] [Abstract][Full Text] [Related]
26. IBS patients show frequent fluctuations between loose/watery and hard/lumpy stools: implications for treatment.
Palsson OS; Baggish JS; Turner MJ; Whitehead WE
Am J Gastroenterol; 2012 Feb; 107(2):286-95. PubMed ID: 22068664
[TBL] [Abstract][Full Text] [Related]
27. Tegaserod for female patients suffering from IBS with mixed bowel habits or constipation: a randomized controlled trial.
Chey WD; Paré P; Viegas A; Ligozio G; Shetzline MA
Am J Gastroenterol; 2008 May; 103(5):1217-25. PubMed ID: 18477346
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of combination therapy with probiotics and mosapride in patients with IBS without diarrhea: a randomized, double-blind, placebo-controlled, multicenter, phase II trial.
Choi CH; Kwon JG; Kim SK; Myung SJ; Park KS; Sohn CI; Rhee PL; Lee KJ; Lee OY; Jung HK; Jee SR; Jeen YT; Choi MG; Choi SC; Huh KC; Park H
Neurogastroenterol Motil; 2015 May; 27(5):705-16. PubMed ID: 25809913
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and indication optimization of Chinese medicine (Tiao-Chang Ke-Min granules) for diarrhea-predominant irritable bowel syndrome: study protocol for a randomized controlled trial.
Li Q; Zhang BP; Huang SG; Ouyang WW; Xie JH; Wen ZH; Yang XB
Trials; 2018 Jul; 19(1):367. PubMed ID: 29996882
[TBL] [Abstract][Full Text] [Related]
30. A randomized, double-blind, placebo-controlled study to assess efficacy and safety of 0.5 mg and 1 mg alosetron in women with severe diarrhea-predominant IBS.
Krause R; Ameen V; Gordon SH; West M; Heath AT; Perschy T; Carter EG
Am J Gastroenterol; 2007 Aug; 102(8):1709-19. PubMed ID: 17509028
[TBL] [Abstract][Full Text] [Related]
31. Treatment of irritable bowel syndrome with Chinese herbal medicine: a randomized controlled trial.
Bensoussan A; Talley NJ; Hing M; Menzies R; Guo A; Ngu M
JAMA; 1998 Nov; 280(18):1585-9. PubMed ID: 9820260
[TBL] [Abstract][Full Text] [Related]
32. Fecal Microbiota Transplantation Reduces Symptoms in Some Patients With Irritable Bowel Syndrome With Predominant Abdominal Bloating: Short- and Long-term Results From a Placebo-Controlled Randomized Trial.
Holvoet T; Joossens M; Vázquez-Castellanos JF; Christiaens E; Heyerick L; Boelens J; Verhasselt B; van Vlierberghe H; De Vos M; Raes J; De Looze D
Gastroenterology; 2021 Jan; 160(1):145-157.e8. PubMed ID: 32681922
[TBL] [Abstract][Full Text] [Related]
33. Randomised clinical trials: linaclotide phase 3 studies in IBS-C - a prespecified further analysis based on European Medicines Agency-specified endpoints.
Quigley EM; Tack J; Chey WD; Rao SS; Fortea J; Falques M; Diaz C; Shiff SJ; Currie MG; Johnston JM
Aliment Pharmacol Ther; 2013 Jan; 37(1):49-61. PubMed ID: 23116208
[TBL] [Abstract][Full Text] [Related]
34. Histamine Receptor H1-Mediated Sensitization of TRPV1 Mediates Visceral Hypersensitivity and Symptoms in Patients With Irritable Bowel Syndrome.
Wouters MM; Balemans D; Van Wanrooy S; Dooley J; Cibert-Goton V; Alpizar YA; Valdez-Morales EE; Nasser Y; Van Veldhoven PP; Vanbrabant W; Van der Merwe S; Mols R; Ghesquière B; Cirillo C; Kortekaas I; Carmeliet P; Peetermans WE; Vermeire S; Rutgeerts P; Augustijns P; Hellings PW; Belmans A; Vanner S; Bulmer DC; Talavera K; Vanden Berghe P; Liston A; Boeckxstaens GE
Gastroenterology; 2016 Apr; 150(4):875-87.e9. PubMed ID: 26752109
[TBL] [Abstract][Full Text] [Related]
35. Clinical trial: lubiprostone in patients with constipation-associated irritable bowel syndrome--results of two randomized, placebo-controlled studies.
Drossman DA; Chey WD; Johanson JF; Fass R; Scott C; Panas R; Ueno R
Aliment Pharmacol Ther; 2009 Feb; 29(3):329-41. PubMed ID: 19006537
[TBL] [Abstract][Full Text] [Related]
36. A randomized, double-blind, placebo-controlled trial of St John's wort for treating irritable bowel syndrome.
Saito YA; Rey E; Almazar-Elder AE; Harmsen WS; Zinsmeister AR; Locke GR; Talley NJ
Am J Gastroenterol; 2010 Jan; 105(1):170-7. PubMed ID: 19809408
[TBL] [Abstract][Full Text] [Related]
37. Treatment of irritable bowel syndrome with a novel colonic irrigation system: a pilot study.
Hsu HH; Leung WH; Hu GC
Tech Coloproctol; 2016 Aug; 20(8):551-7. PubMed ID: 27194235
[TBL] [Abstract][Full Text] [Related]
38. Factors Associated With Response to Placebo in Patients With Irritable Bowel Syndrome and Constipation.
Ballou S; Beath A; Kaptchuk TJ; Hirsch W; Sommers T; Nee J; Iturrino J; Rangan V; Singh P; Jones M; Lembo A
Clin Gastroenterol Hepatol; 2018 Nov; 16(11):1738-1744.e1. PubMed ID: 29654913
[TBL] [Abstract][Full Text] [Related]
39. The effect of 'Zesy002' kiwifruit (
Eady SL; Wallace AJ; Butts CA; Hedderley D; Drummond L; Ansell J; Gearry RB
J Nutr Sci; 2019; 8():e18. PubMed ID: 31080591
[TBL] [Abstract][Full Text] [Related]
40. Tenapanor Treatment of Patients With Constipation-Predominant Irritable Bowel Syndrome: A Phase 2, Randomized, Placebo-Controlled Efficacy and Safety Trial.
Chey WD; Lembo AJ; Rosenbaum DP
Am J Gastroenterol; 2017 May; 112(5):763-774. PubMed ID: 28244495
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
